Company Ningbo Menovo Pharmaceutical Co., Ltd.

Equities

603538

CNE100002Y25

Pharmaceuticals

End-of-day quote Shanghai S.E. 18:00:00 2024-06-26 EDT 5-day change 1st Jan Change
11.14 CNY -3.05% Intraday chart for Ningbo Menovo Pharmaceutical Co., Ltd. -2.19% -41.74%

Business Summary

Ningbo Menovo Pharmaceutical Co Ltd is a China-based company mainly engaged in the research, development, production and sales of pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and preparations. The Company is mainly engaged in three businesses. The contract development and manufacturing organization (CDMO) business mainly provides pharmaceutical companies with CDMO services for the entire preparation industry chain. The specialty API business is mainly engaged in the production and sales of APIs. The preparation business is mainly engaged in the production and sales of preparations. The Company's main products include valsartan, losartan, perindopril, rosuvastatin calcium, atorvastatin calcium and pregabalin. The Company's products are mainly used in cardiovascular, central nervous, antiviral, hypoglycemic, gastrointestinal and other therapeutic areas. The Company mainly conducts its businesses in domestic and overseas markets.

Number of employees: 2,353

Sales per Business

CNY in Million2022Weight2023Weight Delta
Intermediates and Raw Materials
61.4 %
681 46.7 % 747 61.4 % +9.72%
Preparation
18.2 %
223 15.3 % 221 18.2 % -0.74%
Contract Development and Manufacturing Organization
16.5 %
504 34.6 % 201 16.5 % -60.23%
Trading
3.3 %
32 2.2 % 40 3.3 % +25.65%
Other Business
0.6 %
17 1.2 % 8 0.6 % -55.14%

Sales per region

CNY in Million2022Weight2023Weight Delta
Overseas
60.7 %
527 36.6 % 734 60.7 % +39.27%
China
39.3 %
913 63.4 % 475 39.3 % -47.97%

Managers

Managers TitleAgeSince
Chief Executive Officer 49 04-02-18
Director of Finance/CFO 53 19-10-11
Investor Relations Contact - -
Corporate Officer/Principal 41 -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 54 18-06-19
Chief Executive Officer 49 04-02-18
Corporate Officer/Principal 41 -
Director/Board Member 42 18-06-19
Director/Board Member 67 18-06-19
Director/Board Member 53 18-06-19
Director/Board Member 35 21-05-11
Director of Finance/CFO 53 19-10-11
Director/Board Member 36 22-01-26
Chairman 53 21-12-06

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 213,351,489 147,771,818 ( 69.26 %) 2,059,450 ( 0.9653 %) 69.26 %

Shareholders

NameEquities%Valuation
Rongtong Fund Management Co., Ltd.
1.737 %
3,667,000 1.737 % 6 M ¥
Chang Xin Asset Management Co., Ltd.
1.641 %
3,464,576 1.641 % 6 M ¥
Everbright PGIM Fund Management Co. Ltd.
0.9953 %
2,101,631 0.9953 % 4 M ¥
ABC-CA Fund Management Co., Ltd.
0.4060 %
857,221 0.4060 % 1 M ¥
Yinhua Fund Management Co., Ltd.
0.3686 %
778,400 0.3686 % 1 M ¥
GF Fund Management Co., Ltd.
0.3325 %
701,993 0.3325 % 1 M ¥
Great Wall Fund Management Co., Ltd.
0.2936 %
620,000 0.2936 % 1 M ¥
Guotai Asset Management Co., Ltd.
0.1039 %
219,351 0.1039 % 379 414 ¥
Wanjia Asset Management Co., Ltd.
0.0952 %
201,100 0.0952 % 347 845 ¥
Qian Cao
0.0910 %
192,103 0.0910 % 332 282 ¥
NameEquities%Valuation
Qian Cao
3.113 %
69,851 3.113 % 120 822 ¥

Company contact information

Ningbo Menovo Pharmaceutical Co., Ltd.

Room 1406 No. 1, Lane 999, Yangfan Road

315048, Ningbo

+

http://www.menovopharm.com
address Ningbo Menovo Pharmaceutical Co., Ltd.(603538)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
11.14
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 603538 Stock
  4. Company Ningbo Menovo Pharmaceutical Co., Ltd.